Navigation Links
DePuy Pinnacle Lawsuits Stayed in Federal Litigation Pending Completion of First Bellwether Trials, Bernstein Liebhard LLP Reports
Date:10/1/2013

New York, New York (PRWEB) October 01, 2013

DePuy Pinnacle lawsuits (http://www.consumerinjurylawyers.com/depuy-pinnacle/lawsuit) involving a metal-on-metal version of the DePuy Pinnacle Hip Replacement System continue to move towards trial in a multidistrict litigation now underway in U.S. District Court, Northern District of Texas, Bernstein Liebhard LLP reports. According to an Order dated September 30, 2013, the Court has stayed all Pinnacle hip lawsuits filed in the proceeding, with the exception of those selected for its bellwether trials, pending the completion of those trials. Court documents indicate that federal Pinnacle hip lawsuits will begin going before juries in September 2014. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244; N.D. Texas)

“Our Firm is looking forward to the commencement of bellwether trials in this litigation, as it is likely that their outcomes will provide some insight into how juries might rule in similar DePuy Pinnacle lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. Jeffrey S. Grand, a partner with the Firm, serves on the Plaintiffs’ Steering Committee for federally-filed Pinnacle hip lawsuits. Bernstein Liebhard LLP continues to offer free legal evaluations to alleged victims of serious complications associated with the all-metal DePuy Pinnacle Hip Replacement System.

Pinnacle Hip Lawsuits
According to court documents, the DePuy Pinnacle hip at the center of the federal litigation underway in Texas is a metal-on-metal device that utilizes the Ultamet liner. Plaintiffs in Pinnacle hip lawsuits claim that this design allows the hip to shed dangerous amounts of toxic metal debris into a recipient’s tissue and the blood stream, resulting in metallosis, pain, swelling, premature failure of the implant, and need for revision surgery. Plaintiffs also assert that the all-metal Pinnacle is similar in design to the ASR hip, which DePuy Orthopaedics recalled in 2010. They question whether or not this version of the Pinnacle should have been removed from the market as well. Court records indicate that more than 4,800 DePuy Pinnacle lawsuits are now pending in the federal litigation.

On May 17th, The New York Times reported that DePuy Orthopaedics had decided to phase out sales of all-metal hips, including the metal-on-metal version of the Pinnacle, due in part to the recent actions taken by the U.S. Food & Drug Administration (FDA).* DePuy’s decision followed an FDA announcement in January regarding a new regulatory proposal that, if adopted, would require the manufacturers of metal-on-metal hips currently on the market to conduct post-market safety studies of those products in order to keep selling them.

Victims of serious complications allegedly caused by the metal-on-metal DePuy Pinnacle hip may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. Click Here to learn how to contact a DePuy Pinnacle lawyer at Bernstein Liebhard LLP today. For a free evaluation of your Pinnacle hip lawsuit, please contact the Firm by calling 800-511-5092 today.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/depuy-pinnacle-lawsuit/pinnacle-hip-lawsuit/prweb11184709.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Lawsuits Move Forward in New Jersey, as Bernstein Liebhard LLP Notes Upcoming Pretrial Conference
2. DePuy Pinnacle Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pinnacle Hip Litigation
3. DePuy ASR Lawsuit: First Bellwether Trial in Federal DePuy ASR Recall Litigation Postponed For Up To 90 Days, Bernstein Liebhard LLP Reports
4. DePuy Orthopaedics Inc.’s Multidistrict Litigation Update: First Bellwether Trial to Commence Within 90 Days, Parker Waichman LLP Reports
5. First Bellwether Trial in Federal DePuy ASR Lawsuit Litigation Scheduled to Begin after Two-Week Postponement
6. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Certification of DePuy ASR Recall Class Action Lawsuit in Canada
7. DePuy ASR Hip Lawsuit News: Calif. Judge to Determine If Metal-On-Metal Case Will Go to Trial, Rottenstein Law Group LLP Reports
8. DePuy ASR Hip Replacement Lawsuit Trial: Jury Selection in First Federal Trial of DePuy ASR Hip Recall Lawsuit to Begin on September 24th, Wright & Schulte LLC Reports
9. DePuy Pinnacle Lawsuits: Bernstein Liebhard LLP Reports on Latest Developments in Federal Pinnacle Hip Lawsuits
10. Judge Orders Postponement of First Bellwether Trial in DePuy Orthopaedics Inc.’s Multidistrict Litigation, Pushing It to Sept. 24, Parker Waichman LLP Reports
11. DePuy Hip Replacement Lawsuit News: Lawyers at Wright & Schulte LLC Await Start of First Federal Bellwether Trial in DePuy ASR Hip Recall Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... Republicans in the United States Senate on Thursday released their version of ... differs significantly from the American Health Care Act, which the House passed in May, ... will have to take up the Senate version as-is, if it passes. , The ...
(Date:6/25/2017)... ... 25, 2017 , ... CareSet Labs released the Root NPI Graph today at ... new, greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. ... subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as ...
(Date:6/25/2017)... , ... June 25, 2017 , ... June is Men’s Health Month and ... most common cancer among men in the U.S. and the third most common cause of ... estimated that one man in seven will be diagnosed with prostate cancer during his lifetime. ...
(Date:6/24/2017)... Erie, PA (PRWEB) , ... June 24, 2017 ... ... was held in Erie, PA at the Sheraton Erie Bayfront and Erie Convention ... hands-on evidence based medicine experience, exhibits, a student quiz bowl, award and scholarship ...
(Date:6/24/2017)... ... ... The weather is heating up and the days are getting longer, providing the ... the summer months provide more than warmer temperatures that are perfect for BBQ’s and ... from direct exposure to the sun. When it comes to the security of homes ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
(Date:6/14/2017)... 2017  In 2016, Embodied Labs took ... competition and came away with $25,000 in seed-fund investment. ... Forbes as "entering the life of another" and by ... "empathy to medical professionals in an entirely new dimension." ... a finalist for the Department of Education,s EdSimChallenge, where ...
(Date:6/11/2017)... 10, 2017  Eli Lilly and Company (NYSE: ... 3 studies of galcanezumab, an investigational treatment for the ... on several key secondary endpoints for galcanezumab compared to ... studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today ... in Boston . ...
Breaking Medicine Technology: